MT Newswires
Market Chatter: Moderna Curbing Vaccine Trial Investments Over Backlash From US Officials
π
AI Sentiment
Negative
2/10
Latest updates and market news for MRNA
AI Sentiment
Negative
2/10
AI Sentiment
Positive
7/10
AI Sentiment
Highly Positive
9/10
AI Sentiment
Positive
6/10
AI Sentiment
Positive
7/10
AI Sentiment
Highly Positive
8/10
Share this news page